financetom
Business
financetom
/
Business
/
US oilfield firms face pricing squeeze as fracking demand slumps
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US oilfield firms face pricing squeeze as fracking demand slumps
Jan 28, 2025 3:34 AM

HOUSTON (Reuters) - Top U.S. oilfield services firms are facing weaker pricing and revenue this year as oil producers become increasingly efficient and keep a cap on spending, according to oilfield executives and analysts.

U.S. producers, mainly shale companies which led a fracking revolution that unlocked vast new supplies of crude from rock, are pumping record amounts of oil, but using fewer rigs to do it after the COVID-19 pandemic crushed prices and spurred a boom in company mergers and new efficiencies.

The number of oil rigs has dropped to its lowest since December 2021, according to oil service provider Baker Hughes ( BKR ) . In the Permian basin, the top U.S. oilfield located in West Texas and eastern New Mexico, the rig count is at its lowest since February 2022.

The number of active frac fleets totaled 183 in the week to Jan. 23, its lowest since March 2021, according to data from consultancy Primary Vision.

This year, the oilfield services sector is set to be squeezed again as operators eye weaker crude price forecasts due to oversupply.

U.S. benchmark West Texas Intermediate crude futures , which ended last year largely flat at just below $72 a barrel, will average around $63 in 2025, according to Citi.

Roughly half the Texas and New Mexico-based oil executives surveyed by the Dallas Fed in December said they were using $70-$75 a barrel for capital planning.

Amid softer demand, land rig day rates are set to end the year at their lowest level since the second quarter of 2022, according to consultancy, Rystad Energy.

"Day rates are not great," said Jasen Gast, CEO of Houston-based Oilfield Service Professionals (OSP).

Halliburton ( HAL ), one of the top U.S. fracking firms, saw its revenue fall 9% to $2.2 billion in the fourth quarter and is anticipating a low to mid-single digit decrease from 2024 levels due to lower negotiated prices for some of its equipment.

"We're not immune to pricing," said CEO Jeff Miller.

Rivals are also feeling the pinch. JP Morgan expects Liberty Energy will see its EBITDA per frac fleet decline to $19.9 million in 2025, from $24.7 million in 2024 as pricing pressures hit margins.

"The combination of significant improvements in shale completion efficiency and a softer macro picture is leading to further weakness in the frac market," the analysts said.

LESS WORK, MORE DEBT

The U.S. rig count peaked at 2,031 in September 2008, according to Baker Hughes ( BKR ) , when U.S. oil production was around 4 million barrels per day (bpd), data from the U.S. Energy Information Administration showed.

That compares with just 585 rigs operating when production hit a record high at 13.46 million bpd in October 2024, the data showed.

"In 2023 we were thinking the 2024 (rig count) would likely be down 1-2% compared with 2023, but it was actually down 10-11%, so we did overestimate how resilient some of these companies could be," said Rystad Energy's senior vice president, Thomas Jacob.

"Across the board, any E&P that we talk with, any OFS company, pressure pumper that we've spoken with, they all agreed that the amount of work this year could be slightly down, and pricing is definitely down," Jacob added.

As oilfield firms face lower prices and less work, their debt is rising and more are filing for bankruptcy, according to Hal Wallace, president of Texas-based debt collector Ryan and Jacobs.

Energy companies in hot water would usually owe between $20,000 and $250,000, but that has spiked since November 2023, with some companies' debt mounting to $5 million-$8 million, Wallace said.

In the first two weeks of 2025, energy companies owed a collective $9.59 million, compared with $75.78 million for all of 2024, and $45.55 million for 2023, according to Wallace.

"I've seen more bankruptcies in the last 18 months than I have in a long time. A lot of them seem to be the service companies," Wallace said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Levi Strauss & Co Insider Sold Shares Worth $460,986, According to a Recent SEC Filing
Levi Strauss & Co Insider Sold Shares Worth $460,986, According to a Recent SEC Filing
Apr 1, 2024
08:19 AM EDT, 04/01/2024 (MT Newswires) -- Bradley J. Haas, 10% Owner, on March 28, 2024, sold 23,041 shares in Levi Strauss & Co ( LEVI ) for $460,986. SEC Filing: https://www.sec.gov/Archives/edgar/data/94845/000093583624000326/xslF345X03/ownership.xml Price: 20, Change: +0.01, Percent Change: +0.05 ...
Top Premarket Decliners
Top Premarket Decliners
Apr 1, 2024
08:19 AM EDT, 04/01/2024 (MT Newswires) -- Fractyl Health ( GUTS ) shares fell 19% Monday premarket after the company reported a wider Q4 net loss. CalciMedica ( CALC ) shares dropped 18% following a muted session. Vivos Therapeutics ( VVOS ) shares decreased by 17% after the company late Thursday reported lower annual revenue for the year ended Dec....
Sector Update: Consumer
Sector Update: Consumer
Apr 1, 2024
08:21 AM EDT, 04/01/2024 (MT Newswires) -- Consumer stocks were leaning higher pre-bell Monday with the Consumer Staples Select Sector SPDR Fund (XLP) recently inactive, while the Consumer Discretionary Select Sector SPDR Fund (XLY) was up 0.1%. Doma Holdings ( DOMA ) rose more than 35% after announcing its pending takeover by Title Resources Group for $6.29 per share in...
Antibe Therapeutics Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Antibe Therapeutics Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Apr 1, 2024
08:26 AM EDT, 04/01/2024 (MT Newswires) -- Antibe Therapeutics Inc. ( ATBPF ) , which gained more than 4.5% last Thursday, on Monday announced that it received verbal notice from the U.S. Food and Drug Administration on March 28 that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial. Antibe expects to receive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved